CD274 and non-small cell lung carcinoma: PD-L1 expression was evaluated as a predictor of unfavorable prognosis for many other malignant cancers such as NSCLC, melanoma, renal cancer, glioblastoma (GBM), ovarian cancer, and colon cancer.